Bidvest-subsidiary Adcock Ingram says profits improved in the year to end-June, thanks in part to better sales of prescription medication.

That helped boost the company’s shares as much as 5.4% to R58.48 on Wednesday morning...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.